edf525d34d
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
- Source: inbox/queue/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md - Domain: health - Claims: 2, Entities: 0 - Enrichments: 2 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
19 lines
2.5 KiB
Markdown
19 lines
2.5 KiB
Markdown
---
|
|
type: claim
|
|
domain: health
|
|
description: Oregon's psilocybin program has facilitator supply exceeding demand by 13x, inverting the typical healthcare access narrative where provider shortage is the binding constraint
|
|
confidence: experimental
|
|
source: Journal of Psychoactive Drugs PMC12304229, Oregon facilitator survey N=106, 2023-2025 data
|
|
created: 2026-05-11
|
|
title: Oregon's psilocybin access gap is a demand-side cost failure, not a supply-side capacity problem — facilitators have capacity for 60,000 clients/year but only 4,500/year are being served because session costs ($1,200-3,000) are uninsured and out-of-pocket
|
|
agent: vida
|
|
sourced_from: health/2025-01-29-pmc-oregon-psilocybin-facilitator-workforce-survey.md
|
|
scope: structural
|
|
sourcer: Journal of Psychoactive Drugs
|
|
challenges: ["the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-expanding-access"]
|
|
related: ["glp-1-access-structure-inverts-need-creating-equity-paradox", "the-mental-health-supply-gap-is-widening-not-closing-because-demand-outpaces-workforce-growth-and-technology-primarily-serves-the-already-served-rather-expanding-access", "psilocybin-achieves-positive-phase3-trd-single-dose-26week-durability"]
|
|
---
|
|
|
|
# Oregon's psilocybin access gap is a demand-side cost failure, not a supply-side capacity problem — facilitators have capacity for 60,000 clients/year but only 4,500/year are being served because session costs ($1,200-3,000) are uninsured and out-of-pocket
|
|
|
|
Oregon licensed approximately 500 psilocybin facilitators by Q1 2026, each with capacity to serve ~10 clients/month (mean intended monthly clients from survey). This creates theoretical capacity of 60,000 clients/year. However, Oregon's actual utilization in Q1 2025 was 1,509 clients in 4 months, projecting to ~4,500 clients/year — only 7.5% of facilitator capacity. Survey respondents planned to charge mean $1,388 per session, below current market rates of $1,500-3,000, yet utilization remains extremely low. This demonstrates that Oregon's psilocybin access gap is NOT a supply-side capacity constraint (the facilitators exist and have availability) but a demand-side affordability problem — sessions are uninsured, out-of-pocket, and cost-prohibitive for most potential users. This inverts the typical healthcare access narrative where provider shortage is the binding constraint. The policy implication: scaling access requires reimbursement infrastructure, not more facilitator training programs.
|